Sanchez Gabriel, Bondy-Chorney Emma, Laframboise Janik, Paris Geneviève, Didillon Andréanne, Jasmin Bernard J, Côté Jocelyn
Centre for Neuromuscular Disease, Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON K1H 8M5, Canada.
Centre for Neuromuscular Disease, Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON K1H 8M5, Canada
Nucleic Acids Res. 2016 Apr 7;44(6):2661-76. doi: 10.1093/nar/gkv1334. Epub 2015 Dec 9.
Loss of 'Survival of Motor Neurons' (SMN) leads to spinal muscular atrophy (SMA), a disease characterized by degeneration of spinal cord alpha motor neurons, resulting in muscle weakness, paralysis and death during early childhood. SMN is required for assembly of the core splicing machinery, and splicing defects were documented in SMA. We previously uncovered that Coactivator-Associated Methyltransferase-1 (CARM1) is abnormally up-regulated in SMA, leading to mis-regulation of a number of transcriptional and alternative splicing events. We report here that CARM1 can promote decay of a premature terminating codon (PTC)-containing mRNA reporter, suggesting it can act as a mediator of nonsense-mediated mRNA decay (NMD). Interestingly, this pathway, while originally perceived as solely a surveillance mechanism preventing expression of potentially detrimental proteins, is now emerging as a highly regulated RNA decay pathway also acting on a subset of normal mRNAs. We further show that CARM1 associates with major NMD factor UPF1 and promotes its occupancy on PTC-containing transcripts. Finally, we identify a specific subset of NMD targets that are dependent on CARM1 for degradation and that are also misregulated in SMA, potentially adding exacerbated targeting of PTC-containing mRNAs to the already complex array of molecular defects associated with this disease.
“运动神经元存活”(SMN)的缺失会导致脊髓性肌萎缩症(SMA),这是一种以脊髓α运动神经元变性为特征的疾病,会导致幼儿期肌肉无力、瘫痪甚至死亡。SMN是核心剪接机制组装所必需的,并且在SMA中已记录到剪接缺陷。我们之前发现共激活因子相关甲基转移酶-1(CARM1)在SMA中异常上调,导致许多转录和可变剪接事件的调控异常。我们在此报告,CARM1可促进含提前终止密码子(PTC)的mRNA报告基因的降解,表明它可作为无义介导的mRNA降解(NMD)的介质。有趣的是,这条途径虽然最初被认为仅仅是一种防止潜在有害蛋白质表达的监测机制,但现在正逐渐成为一种高度调控的RNA降解途径,也作用于一部分正常mRNA。我们进一步表明,CARM1与主要的NMD因子UPF1结合,并促进其在含PTC转录本上的占据。最后,我们确定了一个特定的NMD靶标子集,它们的降解依赖于CARM1,并且在SMA中也存在调控异常,这可能会使含PTC的mRNA的靶向降解加剧,从而增加了与该疾病相关的已经很复杂的分子缺陷。